Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
160 hedge funds and large institutions have $621M invested in Meridian Bioscience Inc in 2014 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 59 reducing their positions, and 22 closing their positions.
0% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 22
1% less funds holding
Funds holding: 161 → 160 (-1)
11% less capital invested
Capital invested by funds: $695M → $621M (-$74.1M)
12% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 59
96% less call options, than puts
Call options by funds: $41K | Put options by funds: $1.06M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PP
Prudential plc
London, England,
United Kingdom
|
+$5.95M |
| 2 |
Millennium Management
New York
|
+$4.64M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.97M |
| 4 |
Morgan Stanley
New York
|
+$3.62M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$3.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$25.5M |
| 2 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
-$9.92M |
| 3 |
PIM
Perkins Investment Management
Chicago,
Illinois
|
-$8.45M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$8.21M |
| 5 |
CAI
Capital Advisors Inc
Tulsa,
Oklahoma
|
-$3.97M |
VIVO Hedge Fund Activity: Q4 2014 in Review
160 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q4 2014, worth a combined $621M — down 11% from $695M a quarter earlier.
Fund positioning in VIVO was balanced in Q4 2014: 22 funds opened new positions, 22 closed out, 52 added to existing stakes and 59 trimmed.
The largest buyer was Prudential plc, adding an estimated $5.95M. The largest seller was Bank of New York Mellon, cutting an estimated $25.5M.
- 160 institutional investors held Meridian Bioscience Inc (VIVO) as of Q4 2014, down from 161 in Q3 2014.
- Funds reported $621M of Meridian Bioscience Inc stock for Q4 2014, down 11% quarter-over-quarter.
- 22 funds opened new Meridian Bioscience Inc positions in Q4 2014 and 22 closed out, a net change of 0 holders.
- The largest Meridian Bioscience Inc buyer in Q4 2014 was Prudential plc, an estimated $5.95M added.
- The largest Meridian Bioscience Inc seller in Q4 2014 was Bank of New York Mellon, an estimated $25.5M sold.
Based on aggregated 13F filings for Q4 2014.